Endobronchial Valves Therapy for Advanced Emphysema: A Meta-Analysis of Randomized Trials

See Wei Low, Justin Z. Lee, Hem Desai, Chiu-Hsieh Hsu, Afshin R. Sam, James L Knepler

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Trials suggest that bronchoscopic lung volume reduction (BLVR) with endobronchial valve (EBV) implantation may produce similar effects as lung volume reduction surgery, by inducing atelectasis and reducing hyperinflation through a minimally invasive procedure. This study sought to investigate the efficacy and safety of BLVR with EBV for advanced emphysema. Methods: We searched PubMed, EMBASE, Web of Science, CINAHL, ClinicalTrials.gov, and Cochrane Library databases for randomized controlled trials comparing EBV implantation versus standard medical treatment or sham bronchoscopy. The main outcome of interest was the percentage change of forced expiratory volume in 1 second. Results: Data analyzed from 5 randomized controlled trials with 703 patients revealed improvement in percentage change of forced expiratory volume in 1 second in EBV group compared with control group [weighted mean difference (WMD)=11.43; 95% confidence interval (CI), 6.05-16.80; P<0.0001] and improvement in the St. George’s Respiratory Questionnaire score (WMD=−5.69; 95% CI, −8.67 to −2.70; P=0.0002). There is no difference shown in the 6-minute walking test (WMD=14.12; 95% CI, −4.71 to 32.95; P=0.14). The overall complication rate of EBV was not significantly different except for an increased rate of pneumothorax [relative risk (RR)=8.16; 95% CI, 2.21-30.11; P=0.002), any hemoptysis (RR=5.01; 95% CI, 1.12-22.49; P=0.04)] and valve migration (RR=8.64; 95% CI, 2.01-37.13; P=0.004). Conclusions: BLVR using EBV shows short-term improvement in lung function and quality of life, but with increased risk of minor hemoptysis, pneumothorax, and valve migration. Follow-up data on the studies are needed to determine its long-term efficacy.

Original languageEnglish (US)
JournalJournal of Bronchology and Interventional Pulmonology
DOIs
StateAccepted/In press - Jun 12 2018

Fingerprint

Emphysema
Meta-Analysis
Pneumonectomy
Confidence Intervals
Hemoptysis
Forced Expiratory Volume
Pneumothorax
Therapeutics
Randomized Controlled Trials
Pulmonary Atelectasis
Bronchoscopy
PubMed
Libraries
Walking
Placebos
Quality of Life
Databases
Safety
Lung
Control Groups

Keywords

  • bronchoscope
  • bronchoscopic lung volume reduction
  • emphysema
  • endobronchial valves (EBV)

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Endobronchial Valves Therapy for Advanced Emphysema : A Meta-Analysis of Randomized Trials. / Low, See Wei; Lee, Justin Z.; Desai, Hem; Hsu, Chiu-Hsieh; Sam, Afshin R.; Knepler, James L.

In: Journal of Bronchology and Interventional Pulmonology, 12.06.2018.

Research output: Contribution to journalArticle

@article{bfa30724fedd4bef847d982e09f4bbd2,
title = "Endobronchial Valves Therapy for Advanced Emphysema: A Meta-Analysis of Randomized Trials",
abstract = "Background: Trials suggest that bronchoscopic lung volume reduction (BLVR) with endobronchial valve (EBV) implantation may produce similar effects as lung volume reduction surgery, by inducing atelectasis and reducing hyperinflation through a minimally invasive procedure. This study sought to investigate the efficacy and safety of BLVR with EBV for advanced emphysema. Methods: We searched PubMed, EMBASE, Web of Science, CINAHL, ClinicalTrials.gov, and Cochrane Library databases for randomized controlled trials comparing EBV implantation versus standard medical treatment or sham bronchoscopy. The main outcome of interest was the percentage change of forced expiratory volume in 1 second. Results: Data analyzed from 5 randomized controlled trials with 703 patients revealed improvement in percentage change of forced expiratory volume in 1 second in EBV group compared with control group [weighted mean difference (WMD)=11.43; 95{\%} confidence interval (CI), 6.05-16.80; P<0.0001] and improvement in the St. George’s Respiratory Questionnaire score (WMD=−5.69; 95{\%} CI, −8.67 to −2.70; P=0.0002). There is no difference shown in the 6-minute walking test (WMD=14.12; 95{\%} CI, −4.71 to 32.95; P=0.14). The overall complication rate of EBV was not significantly different except for an increased rate of pneumothorax [relative risk (RR)=8.16; 95{\%} CI, 2.21-30.11; P=0.002), any hemoptysis (RR=5.01; 95{\%} CI, 1.12-22.49; P=0.04)] and valve migration (RR=8.64; 95{\%} CI, 2.01-37.13; P=0.004). Conclusions: BLVR using EBV shows short-term improvement in lung function and quality of life, but with increased risk of minor hemoptysis, pneumothorax, and valve migration. Follow-up data on the studies are needed to determine its long-term efficacy.",
keywords = "bronchoscope, bronchoscopic lung volume reduction, emphysema, endobronchial valves (EBV)",
author = "Low, {See Wei} and Lee, {Justin Z.} and Hem Desai and Chiu-Hsieh Hsu and Sam, {Afshin R.} and Knepler, {James L}",
year = "2018",
month = "6",
day = "12",
doi = "10.1097/LBR.0000000000000527",
language = "English (US)",
journal = "Journal of Bronchology and Interventional Pulmonology",
issn = "1944-6586",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Endobronchial Valves Therapy for Advanced Emphysema

T2 - A Meta-Analysis of Randomized Trials

AU - Low, See Wei

AU - Lee, Justin Z.

AU - Desai, Hem

AU - Hsu, Chiu-Hsieh

AU - Sam, Afshin R.

AU - Knepler, James L

PY - 2018/6/12

Y1 - 2018/6/12

N2 - Background: Trials suggest that bronchoscopic lung volume reduction (BLVR) with endobronchial valve (EBV) implantation may produce similar effects as lung volume reduction surgery, by inducing atelectasis and reducing hyperinflation through a minimally invasive procedure. This study sought to investigate the efficacy and safety of BLVR with EBV for advanced emphysema. Methods: We searched PubMed, EMBASE, Web of Science, CINAHL, ClinicalTrials.gov, and Cochrane Library databases for randomized controlled trials comparing EBV implantation versus standard medical treatment or sham bronchoscopy. The main outcome of interest was the percentage change of forced expiratory volume in 1 second. Results: Data analyzed from 5 randomized controlled trials with 703 patients revealed improvement in percentage change of forced expiratory volume in 1 second in EBV group compared with control group [weighted mean difference (WMD)=11.43; 95% confidence interval (CI), 6.05-16.80; P<0.0001] and improvement in the St. George’s Respiratory Questionnaire score (WMD=−5.69; 95% CI, −8.67 to −2.70; P=0.0002). There is no difference shown in the 6-minute walking test (WMD=14.12; 95% CI, −4.71 to 32.95; P=0.14). The overall complication rate of EBV was not significantly different except for an increased rate of pneumothorax [relative risk (RR)=8.16; 95% CI, 2.21-30.11; P=0.002), any hemoptysis (RR=5.01; 95% CI, 1.12-22.49; P=0.04)] and valve migration (RR=8.64; 95% CI, 2.01-37.13; P=0.004). Conclusions: BLVR using EBV shows short-term improvement in lung function and quality of life, but with increased risk of minor hemoptysis, pneumothorax, and valve migration. Follow-up data on the studies are needed to determine its long-term efficacy.

AB - Background: Trials suggest that bronchoscopic lung volume reduction (BLVR) with endobronchial valve (EBV) implantation may produce similar effects as lung volume reduction surgery, by inducing atelectasis and reducing hyperinflation through a minimally invasive procedure. This study sought to investigate the efficacy and safety of BLVR with EBV for advanced emphysema. Methods: We searched PubMed, EMBASE, Web of Science, CINAHL, ClinicalTrials.gov, and Cochrane Library databases for randomized controlled trials comparing EBV implantation versus standard medical treatment or sham bronchoscopy. The main outcome of interest was the percentage change of forced expiratory volume in 1 second. Results: Data analyzed from 5 randomized controlled trials with 703 patients revealed improvement in percentage change of forced expiratory volume in 1 second in EBV group compared with control group [weighted mean difference (WMD)=11.43; 95% confidence interval (CI), 6.05-16.80; P<0.0001] and improvement in the St. George’s Respiratory Questionnaire score (WMD=−5.69; 95% CI, −8.67 to −2.70; P=0.0002). There is no difference shown in the 6-minute walking test (WMD=14.12; 95% CI, −4.71 to 32.95; P=0.14). The overall complication rate of EBV was not significantly different except for an increased rate of pneumothorax [relative risk (RR)=8.16; 95% CI, 2.21-30.11; P=0.002), any hemoptysis (RR=5.01; 95% CI, 1.12-22.49; P=0.04)] and valve migration (RR=8.64; 95% CI, 2.01-37.13; P=0.004). Conclusions: BLVR using EBV shows short-term improvement in lung function and quality of life, but with increased risk of minor hemoptysis, pneumothorax, and valve migration. Follow-up data on the studies are needed to determine its long-term efficacy.

KW - bronchoscope

KW - bronchoscopic lung volume reduction

KW - emphysema

KW - endobronchial valves (EBV)

UR - http://www.scopus.com/inward/record.url?scp=85048639811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048639811&partnerID=8YFLogxK

U2 - 10.1097/LBR.0000000000000527

DO - 10.1097/LBR.0000000000000527

M3 - Article

C2 - 29901536

AN - SCOPUS:85048639811

JO - Journal of Bronchology and Interventional Pulmonology

JF - Journal of Bronchology and Interventional Pulmonology

SN - 1944-6586

ER -